However, exosomes harbored with SIRPα variants (SIRPα-exosomes) could break the association between CD47 and SIRPα and relieve the resistance of phagocytic cell, which provides a strategy for enhancing immune response to cancers based on exosomal proteins 116. This evidence concerns the gene SIRPA and cancer.